Xiangdong Lu

589 total citations
24 papers, 455 citations indexed

About

Xiangdong Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiangdong Lu has authored 24 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Xiangdong Lu's work include Epigenetics and DNA Methylation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related Molecular Pathways (5 papers). Xiangdong Lu is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related Molecular Pathways (5 papers). Xiangdong Lu collaborates with scholars based in China, United States and Norway. Xiangdong Lu's co-authors include Weidong Mao, Qiong Wang, Feng Lin, Tao Liu, Dong Shen, Terry Van Dyke, Katrien Wijndaele, Ulf Ekelund, Qingfeng Lin and Tao Zhao and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Xiangdong Lu

22 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangdong Lu China 12 255 125 101 66 54 24 455
Liang Zhuang China 12 188 0.7× 144 1.2× 93 0.9× 42 0.6× 22 0.4× 28 398
Paweł Knapp Poland 14 242 0.9× 163 1.3× 128 1.3× 50 0.8× 37 0.7× 67 629
Amy Dresen United States 8 222 0.9× 137 1.1× 88 0.9× 50 0.8× 16 0.3× 14 473
Truong Lam United States 9 206 0.8× 63 0.5× 58 0.6× 42 0.6× 83 1.5× 16 390
Byeong Jin Ye South Korea 15 178 0.7× 69 0.6× 54 0.5× 37 0.6× 24 0.4× 26 473
Mark Hamilton United States 9 194 0.8× 147 1.2× 38 0.4× 113 1.7× 50 0.9× 26 560
R. Wilson United Kingdom 10 270 1.1× 194 1.6× 36 0.4× 35 0.5× 42 0.8× 20 502
Miriam McQuade United States 6 346 1.4× 70 0.6× 193 1.9× 47 0.7× 16 0.3× 14 513
Brittany A. Simone United States 11 215 0.8× 88 0.7× 181 1.8× 154 2.3× 24 0.4× 25 457

Countries citing papers authored by Xiangdong Lu

Since Specialization
Citations

This map shows the geographic impact of Xiangdong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangdong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangdong Lu more than expected).

Fields of papers citing papers by Xiangdong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangdong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangdong Lu. The network helps show where Xiangdong Lu may publish in the future.

Co-authorship network of co-authors of Xiangdong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangdong Lu. A scholar is included among the top collaborators of Xiangdong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangdong Lu. Xiangdong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Tao, Jinghui Sun, Xiangdong Lu, et al.. (2023). Let‐7a‐5p abrogates progression of papillary thyroid carcinoma cells by decreasing nuclear receptor subfamily 6 group a member 1‐mediated lipogenesis. Journal of Biochemical and Molecular Toxicology. 38(1). e23572–e23572. 2 indexed citations
2.
Zhao, Tao, et al.. (2022). Paclitaxel Resistance Modulated by the Interaction between TRPS1 and AF178030.2 in Triple-Negative Breast Cancer. Evidence-based Complementary and Alternative Medicine. 2022. 1–9. 14 indexed citations
3.
Sun, Xia, Xianting Huang, Xiangdong Lu, et al.. (2021). The expression and clinical significance of the tRNA aspartic acid methyltransferase 1 protein in gastric cancer. International Journal of Clinical Oncology. 26(12). 2229–2236. 5 indexed citations
4.
Lu, Xiangdong, et al.. (2020). Overexpression of CTEN is associated with gefitinib resistance in non‑small cell lung cancer. Oncology Letters. 21(1). 1–1. 7 indexed citations
5.
Chen, Jie, Tingting Ni, Jiyi Zhao, et al.. (2020). NLK interacts with 14‑3‑3ζ to restore the expression of E‑cadherin. Oncology Reports. 3 indexed citations
6.
7.
Lu, Xiangdong, et al.. (2019). Down-regulation of microRNA-10a mediates the anti-tumor effect of icaritin in A549 cells via the PTEN/AKT and ERK pathway. General Physiology and Biophysics. 38(6). 525–533. 19 indexed citations
8.
Lu, Xiangdong, Chi-Shuen Chu, Terry Fang, et al.. (2019). MTA2/NuRD Regulates B Cell Development and Cooperates with OCA-B in Controlling the Pre-B to Immature B Cell Transition. Cell Reports. 28(2). 472–485.e5. 26 indexed citations
9.
Lu, Xiangdong, et al.. (2018). CTEN induces epithelial-mesenchymal transition (EMT) and metastasis in non small cell lung cancer cells. PLoS ONE. 13(7). e0198823–e0198823. 16 indexed citations
10.
Lu, Xiangdong, et al.. (2018). Nicotinamide N-methyltransferase as a potential marker for cancer. Neoplasma. 65(5). 656–663. 37 indexed citations
11.
Lu, Xiangdong, Jingjing Ma, Jiahui Chu, et al.. (2017). MiR-129-5p Sensitizes the Response of Her-2 Positive Breast Cancer to Trastuzumab by Reducing Rps6. Cellular Physiology and Biochemistry. 44(6). 2346–2356. 30 indexed citations
12.
Chen, Xiang, Rui Duan, Yucui Jin, et al.. (2017). Osterix Decreases the Chemosensitivity of Breast Cancer Cells by Upregulating GALNT14. Cellular Physiology and Biochemistry. 44(3). 998–1010. 5 indexed citations
13.
Gao, Yong, et al.. (2015). MicroRNA-18a regulates invasive meningiomas via hypoxia-inducible factor-1α. Experimental and Therapeutic Medicine. 10(3). 1165–1170. 11 indexed citations
14.
Shen, Dong, Weidong Mao, Tao Liu, et al.. (2014). Sedentary Behavior and Incident Cancer: A Meta-Analysis of Prospective Studies. PLoS ONE. 9(8). e105709–e105709. 100 indexed citations
16.
Lu, Xiangdong, Liangliang Cui, Yan Ma, et al.. (2012). [A viral meningitis outbreak associated with Echo30 in drinking water].. PubMed. 33(10). 1067–71. 2 indexed citations
17.
Lu, Xiangdong, Chunyu Yang, Chaoying Yin, Terry Van Dyke, & Karl Simin. (2011). Apoptosis Is the Essential Target of Selective Pressure against p53, whereas Loss of Additional p53 Functions Facilitates Carcinoma Progression. Molecular Cancer Research. 9(4). 430–439. 5 indexed citations
18.
Lu, Xiangdong, Chunyu Yang, Reginald Hill, et al.. (2008). Inactivation of gadd45a Sensitizes Epithelial Cancer Cells to Ionizing Radiation In vivo Resulting in Prolonged Survival. Cancer Research. 68(10). 3579–3583. 13 indexed citations
19.
Lu, Xiangdong, Kovalev Gi, Hua Chang, et al.. (2008). Inactivation of NuRD Component Mta2 Causes Abnormal T Cell Activation and Lupus-like Autoimmune Disease in Mice. Journal of Biological Chemistry. 283(20). 13825–13833. 49 indexed citations
20.
Lu, Xiangdong, Gregg Magrane, Chaoying Yin, et al.. (2001). Selective Inactivation of p53 Facilitates Mouse Epithelial Tumor Progression without Chromosomal Instability. Molecular and Cellular Biology. 21(17). 6017–6030. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026